To whom should violations related to the Care Plus Medical Ucc disclosure document be reported?

According to Care Plus Medical Ucc's 2024 Franchise Disclosure Document, if the document is not delivered on time, contains false or misleading statements, or has material omissions, a violation of federal and state law may have occurred. In such cases, the violation should be reported to both the Federal Trade Commission (FTC) in Washington, D.C., and any applicable state agency. The relevant state agencies are listed in Exhibit A of the FDD.

This instruction is included in the receipt section of the FDD, emphasizing the importance of franchisees carefully reviewing the disclosure document and all related agreements. The disclosure document is intended to provide a summary of the franchise agreement and other pertinent information in plain language, ensuring that prospective franchisees are well-informed before making any commitments.

For a prospective Care Plus Medical Ucc franchisee, this means understanding their rights and responsibilities regarding the FDD. It is crucial to verify that the document is received within the mandated timeframe and to scrutinize its contents for accuracy and completeness. If any discrepancies or concerns arise, they should be promptly reported to the FTC and the appropriate state agency to protect their investment and legal standing.

Specifically for California franchisees, the California addendum in Exhibit A states that any complaints concerning the content of Care Plus Medical Ucc's website may be directed to the California Department of Financial Protection and Innovation at www.dfpi.ca.gov.